IL42016A0 - Novel dopamine derivatives and their preparation - Google Patents

Novel dopamine derivatives and their preparation

Info

Publication number
IL42016A0
IL42016A0 IL42016A IL4201673A IL42016A0 IL 42016 A0 IL42016 A0 IL 42016A0 IL 42016 A IL42016 A IL 42016A IL 4201673 A IL4201673 A IL 4201673A IL 42016 A0 IL42016 A0 IL 42016A0
Authority
IL
Israel
Prior art keywords
preparation
novel dopamine
dopamine derivatives
derivatives
novel
Prior art date
Application number
IL42016A
Other versions
IL42016A (en
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22918877&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL42016(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of IL42016A0 publication Critical patent/IL42016A0/en
Publication of IL42016A publication Critical patent/IL42016A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00—Compounds containing amino groups bound to a carbon skeleton
    • C07C211/01—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms
    • C07C211/26—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing at least one six-membered aromatic ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/45—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by condensation
    • C07C45/46—Friedel-Crafts reactions
IL42016A 1972-04-12 1973-04-12 Dopamine derivatives and their preparation IL42016A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US24346672A 1972-04-12 1972-04-12

Publications (2)

Publication Number Publication Date
IL42016A0 true IL42016A0 (en) 1973-06-29
IL42016A IL42016A (en) 1976-05-31

Family

ID=22918877

Family Applications (1)

Application Number Title Priority Date Filing Date
IL42016A IL42016A (en) 1972-04-12 1973-04-12 Dopamine derivatives and their preparation

Country Status (31)

Country Link
JP (2) JPS5825656B2 (en)
KR (1) KR790000113B1 (en)
AR (1) AR203822A1 (en)
AT (1) AT323719B (en)
AU (1) AU472734B2 (en)
BE (1) BE798051A (en)
BG (1) BG23001A3 (en)
CA (1) CA1018188A (en)
CH (2) CH580563A5 (en)
CS (2) CS190448B2 (en)
CY (1) CY963A (en)
DD (1) DD107670B3 (en)
DE (1) DE2317710C2 (en)
DK (1) DK142750C (en)
ES (1) ES413639A1 (en)
FR (1) FR2182947B1 (en)
GB (1) GB1392674A (en)
HK (1) HK50178A (en)
HU (2) HU167597B (en)
IE (1) IE37511B1 (en)
IL (1) IL42016A (en)
KE (1) KE2870A (en)
MY (1) MY7800381A (en)
NL (1) NL174459C (en)
PH (1) PH11041A (en)
PL (2) PL94207B1 (en)
RO (2) RO70892A (en)
SE (1) SE399064B (en)
SU (1) SU496719A3 (en)
YU (2) YU36483B (en)
ZA (1) ZA732136B (en)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH585693A5 (en) * 1974-02-08 1977-03-15 Ciba Geigy Ag
US4342692A (en) * 1980-10-20 1982-08-03 Usv Pharmaceutical Corporation Pyrrolidines
ES8702355A1 (en) * 1981-07-22 1985-07-01 Syntex Inc Substituted pyrrolidine cardiovascular system regulators and antihypertensives, their preparation and use.
JPS6061523A (en) * 1983-09-16 1985-04-09 Shionogi & Co Ltd Oral dobutamine pharmaceutical
IL85438A0 (en) * 1987-02-24 1988-07-31 Lilly Co Eli Improvements in or relating to dobutamine salts
JPH0383364U (en) * 1989-12-18 1991-08-23
AU658188B2 (en) * 1991-05-20 1995-04-06 Tsumura & Co. Phellodendrine analogs and allergy type IV suppressor containing the same as active ingredient
ATE155125T1 (en) * 1993-04-13 1997-07-15 Duphar Int Res PRODUCTION OF DOBUTAMIN COMPOUNDS
EP0620208B1 (en) * 1993-04-13 1997-07-09 Duphar International Research B.V Production of dobutamine compounds
DK1546088T3 (en) 2002-10-03 2015-03-30 Novaremed Ltd RELATIONSHIPS FOR USING THE TREATMENT OF AUTO-IMMUNE DISEASES, IMMUNOALLERGIC DISEASES AND ORGAN OR TISSUE TRANSPLANT AID
EP1750691B1 (en) 2004-03-26 2016-08-10 Novaremed Ltd. Compounds for treatment of aids and other diseases
GB0804213D0 (en) 2008-03-06 2008-04-16 New Era Biotech Ltd A method of printing or preventing pain
AU2010278711A1 (en) 2009-07-31 2012-02-23 Cognition Therapeutics, Inc. Inhibitors of cognitive decline
US8802734B2 (en) 2009-09-09 2014-08-12 Novaremed Limited Method of treating or preventing pain
RU2014111079A (en) * 2011-08-25 2015-09-27 Когнишн Терапьютикс, Инк. COMPOSITIONS AND METHODS FOR TREATING A NEURODEGENERATIVE DISEASE
EP4023294A1 (en) 2014-01-31 2022-07-06 Cognition Therapeutics, Inc. Isoindoline compositions and methods for treating alzheimer's disease
CA3061787A1 (en) 2017-05-15 2018-11-22 Cognition Therapeutics, Inc. Compositions for treating neurodegenerative diseases

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2276619A (en) * 1942-03-17 N-phentlaliphatic-dihtoroxyphentnl

Also Published As

Publication number Publication date
PL90695B1 (en) 1977-01-31
IL42016A (en) 1976-05-31
DE2317710C2 (en) 1983-08-04
YU37113B (en) 1984-08-31
FR2182947B1 (en) 1976-07-02
NL174459B (en) 1984-01-16
HU167597B (en) 1975-11-28
ZA732136B (en) 1974-03-27
DD107670A5 (en) 1974-08-12
GB1392674A (en) 1975-04-30
CH580563A5 (en) 1976-10-15
BE798051A (en) 1973-10-11
DD107670B3 (en) 1988-04-06
DK142750B (en) 1981-01-12
RO70892A (en) 1982-02-26
YU97673A (en) 1982-02-25
MY7800381A (en) 1978-12-31
AU472734B2 (en) 1976-06-03
NL7305097A (en) 1973-10-16
KE2870A (en) 1978-09-01
NL174459C (en) 1984-06-18
AR203822A1 (en) 1975-10-31
AU5438573A (en) 1974-10-17
JPS5825656B2 (en) 1983-05-28
ES413639A1 (en) 1976-01-16
CA1018188A (en) 1977-09-27
CS190448B2 (en) 1979-05-31
CY963A (en) 1978-12-22
YU36483B (en) 1984-02-29
DE2317710A1 (en) 1973-10-18
AT323719B (en) 1975-07-25
IE37511B1 (en) 1977-08-03
JPS58131945A (en) 1983-08-06
YU321279A (en) 1983-04-27
DK142750C (en) 1981-08-17
HK50178A (en) 1978-09-15
JPS6221343B2 (en) 1987-05-12
PH11041A (en) 1977-10-25
FR2182947A1 (en) 1973-12-14
KR790000113B1 (en) 1979-03-20
HU166213B (en) 1975-02-28
SE399064B (en) 1978-01-30
PL94207B1 (en) 1977-07-30
SU496719A3 (en) 1975-12-25
CS190406B2 (en) 1979-05-31
JPS497237A (en) 1974-01-22
BG23001A3 (en) 1977-05-20
RO65105A (en) 1980-01-15
CH569691A5 (en) 1975-11-28

Similar Documents

Publication Publication Date Title
IL48141A0 (en) New acyldiamines and their preparation
IL41515A0 (en) 11-deoxyprostaglandin derivatives and their preparation
IL42016A0 (en) Novel dopamine derivatives and their preparation
IL41403A0 (en) New dibenzocycloheptene derivatives and their preparation
IL43589A0 (en) Novel omega-pentanorprostaglandis and their preparation
IL43571A0 (en) Omega-pentanorprostaglandins and their preparation
IL42219A0 (en) 14-hydroxymorphinan derivatives and processes for their preparation
IL41227A0 (en) Substituted 1-chromonyloxy-2-hydroxy-3-phenoxypropanes and their preparation
IL44001A0 (en) Novel 3-substituted 6-phenantridon derivatives and their preparation
IL42691A (en) 15-substituted - - pentanorprostaglandins and their preparation
CY992A (en) Benzocycloheptathiophene derivatives
IL43788A0 (en) Novel phthalides and their preparation
GB1402219A (en) Berbine derivatives
ZA737541B (en) Octahydro aryl-isoquinolines and derivatives thereof
ZA734374B (en) New 3-alkyl-4-sulphamoyl-aniline derivatives and the preparation thereof
ZA734461B (en) Novel 2beta-hydroxy-3alpha-amino-steroids and derivatives thereof and the processes for their preparation
ZA738700B (en) Ethynylindenyl compounds and derivatives thereof
ZA73494B (en) Benzocycloheptathiophene derivatives and their preparation
PH10711A (en) 1-cyclopropyl-1-phenyl-w-amino-1-alkanols and 1-lower-alkylacyl derivatives
CA991643A (en) 3-phenoxypropylamine derivatives and preparation thereof
IL48935A0 (en) 5-hydroxy-1-amino-hydantoin and its preparation
IL40101A0 (en) The preparation of certain indolobenzazepine derivatives
AU6087773A (en) Octahydro-aryl-isoquinolines and derivatives thereof
ZA733032B (en) New cyclopentenoquinolone derivatives and the preparation thereof
IL42373A0 (en) Oxaprostaglandins and their preparation